Aristeidis E. Boukouris

1.0k total citations
13 papers, 493 citations indexed

About

Aristeidis E. Boukouris is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aristeidis E. Boukouris has authored 13 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Aristeidis E. Boukouris's work include Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Aristeidis E. Boukouris is often cited by papers focused on Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related Molecular Pathways (3 papers). Aristeidis E. Boukouris collaborates with scholars based in Canada, Germany and Greece. Aristeidis E. Boukouris's co-authors include Evangelos D. Michelakis, Sotirios Zervopoulos, Bruno Saleme, Gopinath Sutendra, Michael P. Manns, Laura Elisa Buitrago‐Molina, Arndt Vogel, Silke Marhenke, John R. Ussher and Thomas Longerich and has published in prestigious journals such as Molecular Cell, Hepatology and Trends in Biochemical Sciences.

In The Last Decade

Aristeidis E. Boukouris

11 papers receiving 492 citations

Peers

Aristeidis E. Boukouris
Chien-Yu Chen United States
Aristeidis E. Boukouris
Citations per year, relative to Aristeidis E. Boukouris Aristeidis E. Boukouris (= 1×) peers Chien-Yu Chen

Countries citing papers authored by Aristeidis E. Boukouris

Since Specialization
Citations

This map shows the geographic impact of Aristeidis E. Boukouris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aristeidis E. Boukouris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aristeidis E. Boukouris more than expected).

Fields of papers citing papers by Aristeidis E. Boukouris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aristeidis E. Boukouris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aristeidis E. Boukouris. The network helps show where Aristeidis E. Boukouris may publish in the future.

Co-authorship network of co-authors of Aristeidis E. Boukouris

This figure shows the co-authorship network connecting the top 25 collaborators of Aristeidis E. Boukouris. A scholar is included among the top collaborators of Aristeidis E. Boukouris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aristeidis E. Boukouris. Aristeidis E. Boukouris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Papadaki, Chara, Aristeidis E. Boukouris, Maria Markaki, et al.. (2025). MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer. Cancers. 17(15). 2504–2504.
2.
Boukouris, Aristeidis E., Kleita Michaelidou, Simon A. Joosse, et al.. (2025). A comprehensive overview of minimal residual disease in the management of early-stage and locally advanced non-small cell lung cancer. npj Precision Oncology. 9(1). 178–178. 1 indexed citations
3.
Saleme, Bruno, Yongneng Zhang, Yongsheng Liu, et al.. (2025). Hyperacute response proteins synthesized on γ-tubulin-FTO-MARK4 translation microdomains regulate cancer’s acute stress response. Cell Reports. 44(7). 115871–115871.
4.
Maayah, Zaid H., Mourad Ferdaoussi, Aristeidis E. Boukouris, et al.. (2023). Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling. JACC CardioOncology. 5(5). 686–700. 5 indexed citations
5.
Zervopoulos, Sotirios, Aristeidis E. Boukouris, Bruno Saleme, et al.. (2022). MFN2-driven mitochondria-to-nucleus tethering allows a non-canonical nuclear entry pathway of the mitochondrial pyruvate dehydrogenase complex. Molecular Cell. 82(5). 1066–1077.e7. 42 indexed citations
6.
Boukouris, Aristeidis E., Yongneng Zhang, Bruno Saleme, et al.. (2022). A reversible metabolic stress-sensitive regulation of CRMP2A orchestrates EMT/stemness and increases metastatic potential in cancer. Cell Reports. 38(11). 110511–110511. 8 indexed citations
7.
Boukouris, Aristeidis E., et al.. (2022). Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update. Critical Reviews in Oncology/Hematology. 173. 103663–103663. 49 indexed citations
9.
Kinnaird, Adam, Aristeidis E. Boukouris, Bruno Saleme, et al.. (2020). Interaction with p53 explains a pro-proliferative function for VHL in cancer. Journal of Molecular Medicine. 98(9). 1269–1278. 5 indexed citations
10.
Saleme, Bruno, Vikram Gurtu, Yongneng Zhang, et al.. (2019). Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. Science Translational Medicine. 11(478). 57 indexed citations
11.
Boukouris, Aristeidis E., Sotirios Zervopoulos, & Evangelos D. Michelakis. (2016). Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. Trends in Biochemical Sciences. 41(8). 712–730. 211 indexed citations
12.
Buitrago‐Molina, Laura Elisa, Silke Marhenke, Thomas Longerich, et al.. (2013). The Degree of Liver Injury Determines the Role of P21 in Liver Regeneration And Hepatocarcinogenesis in Mice. Hepatology. 58(3). 1143–1152. 72 indexed citations
13.
Kirstein, Martha M., Aristeidis E. Boukouris, Laura Elisa Buitrago‐Molina, et al.. (2013). Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3‐kinase inhibitor BEZ235 and the PI3‐kinase inhibitor BKM120 in hepatocellular carcinoma. Liver International. 33(5). 780–793. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026